Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.RES.527
H.RES.527: Relating to breast implants, the Food and Drug Administration, and public health.
About This Bill
- This bill was introduced in the 104th Congress
- This bill is primarily about education
- Introduced Sept. 19, 1996
- Latest Major Action Sept. 25, 1996
Bill Sponsor
Bill Summary
Expresses the sense of the House of Representatives that the Food and Drug Administration should: (1) ensure that women with breast cancer and other women seeking breast reconstruction have enhanced access to silicone gel breast implants; (2) eliminate requirements that those women participate in clinical studies in order to obtain the implants; and (3) issue a definitive statement on the relationship (or lack thereof) between silicone gel...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the House Committee on Commerce.
|
|
Referred to the Subcommittee on Health and Environment.
|
|
Sept. 19, 1996 |
Introduced in the House by David M. McIntosh (R-Ind.) |